GlassScriptPhysician profile
Yvonne C Goff
NPI 1669556460
$771.34
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $148 · 2021: $67.38.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $218.73 | 2019-2021 | |
| Therapeuticsmd, INC. | $91.34 | 2019-2021 | |
| Allergan, INC. | $87.76 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.27 | 2019 | |
| Amag Pharmaceuticals, INC. | $63.72 | 2019 | |
| Merck Sharp & Dohme LLC | $63.39 | 2019-2020 | |
| Avion Pharmaceuticals | $38.98 | 2019 | |
| Daiichi Sankyo INC. | $34.43 | 2019 | |
| Intuitive Surgical, INC. | $31.92 | 2021 | |
| Exeltis, USA INC. | $21.86 | 2020 | |
| Coopersurgical, INC. | $18.31 | 2019 | |
| Minerva Surgical, INC | $16.63 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvonne Goff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.